New York City residents are bracing for a potential influx of new healthcare services, but a crucial question remains: will the benefits outweigh the costs? A recent proposal to expand the 340B program, which allows certain healthcare providers to purchase discounted medications, has sparked debate among local officials and healthcare advocates. Under the proposed expansion, New York City hospitals and clinics could see significant savings on prescription medications, but critics argue that the increased funding could be mismanaged or lead to unintended consequences. As the city weighs the pros and cons of the expansion, one thing is clear: New Yorkers deserve transparency and a clear understanding of how their tax dollars will be spent.
Opinion | Before expanding 340B, New Yorkers deserves transparency Bronx Times
